Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
126 hedge funds and large institutions have $591M invested in Momenta Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 27 reducing their positions, and 13 closing their positions.
123% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 13
100% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 27
55% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $8.7M
14% more funds holding
Funds holding: 111 → 126 (+15)
7% less capital invested
Capital invested by funds: $635M → $591M (-$43.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$30.7M |
| 2 |
BM
Bridger Management
New York
|
+$18.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$16.8M |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$13.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$65M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$55.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.43M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.25M |
MNTA Hedge Fund Activity: Q3 2013 in Review
126 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q3 2013, worth a combined $591M — down 6.9% from $635M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new MNTA positions and 13 closed out — a net gain of 16 holders — while 54 added to existing stakes and 27 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $30.7M. The largest seller was Visium Asset Management, cutting an estimated $65M.
- 126 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q3 2013, up from 111 in Q2 2013.
- Funds reported $591M of Momenta Pharmaceuticals, Inc. stock for Q3 2013, down 6.9% quarter-over-quarter.
- 29 funds opened new Momenta Pharmaceuticals, Inc. positions in Q3 2013 and 13 closed out, a net change of +16 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q3 2013 was Deerfield Management, an estimated $30.7M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q3 2013 was Visium Asset Management, an estimated $65M sold.
Based on aggregated 13F filings for Q3 2013.